📱 Discover even more news and info on the new, free Axios mobile app. Download on iPhone (Android version coming soon).
Today's word count is 1,371, or a 5-minute read.
Illustration: Aïda Amer/Axios
The U.S. still can't perform many of the public health measures we'd need in order to keep coronavirus infections tightly contained in a reopened economy.
The big picture: Extreme social distancing has bought us some time, but much of the country still lacks some of the critical systems needed to handle waves of new infections once those restrictions begin to lift.
"We have to have something in place that is efficient and that we can rely on, and we’re not there yet," Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, told the Associated Press yesterday.
We would need to be testing people who aren't exhibiting any symptoms — not limiting tests to the sickest patients.
We would need thousands of health care workers across the country to track down, test and potentially isolate people who have interacted with confirmed coronavirus patients.
We would need a plan for how to transition recovering coronavirus patients from hospitals to post-acute care, raising the risk of the virus spreading through nursing homes, assisted living facilities and rehab centers.
The bottom line: Given how much it has cost to lock the U.S. down once, it's unlikely we'll get another chance to get this right.
California Gov. Gavin Newsom released a roadmap on Tuesday that will guide how he will make the decision to relax the stay-at-home policies his state implemented to combat the spread of the coronavirus, Axios' Fadel Allassan reports.
My thought bubble: These steps reflect what public health officials say needs to be done, but as I just told you, we still have a ways to go.
Details: Newsom said California would use six indicators to determine when to relax social distancing measures:
Newsom's roadmap also notes that life will be different even after stay-at-home orders are eased. For example, restaurants will likely reopen with fewer tables and face coverings will be more common in public.
What he's saying: "There is no light switch here. Think of it as a dimmer. It will toggle between less restrictive and more restrictive," Newsom said.
The number of novel coronavirus cases in the U.S. now exceeds 600,000, per Johns Hopkins. More than 3.12 million tests have been conducted and nearly 50,000 Americans have recovered from the virus as of this morning.
More than 10,000 people have died in New York City due to the coronavirus in confirmed and probable cases, per newly released data from the city's health department.
Doctors, nurses and other health care personnel constitute up to 19% of confirmed coronavirus cases in the U.S., a new analysis from the Centers for Disease Control and Prevention shows.
U.S. mayors have banded together to ask Congress for $250 billion in direct funding to help cities deal with the enormous costs of fighting the coronavirus pandemic while also facing significant revenue loss from shutdowns of local economies, Axios' Kim Hart reports.
New York Gov. Andrew Cuomo took to MSNBC's "Morning Joe" Tuesday to push back on President Trump's assertion that he has the sole authority to end states' stay-at-home measures and move to reopen the economy from the coronavirus crisis.
While industry giants reassure shoppers there is enough food during the coronavirus pandemic, people continue to be met with empty supermarket shelves due to stresses on established supply chains, the Washington Post reports.
President Trump announced Tuesday that the U.S. is placing a hold on funding to the World Health Organization for 60–90 days over its handling of the coronavirus pandemic, pending a review.
Driving the news: Trump accused the WHO of "severely mismanaging and covering up" the coronavirus crisis, adding that the U.S. "has a duty to insist on full accountability."
By the numbers: The WHO's 2018-2019 budget was about $6 billion, and the U.S. is by far the biggest donor of any country, contributing more than $400 million to the organization last year.
The U.S. is still scrambling to get health care workers the personal protective equipment, ventilators and lab testing materials that they need.
Between the lines: President Trump has repeatedly said that governors are responsible for obtaining supplies for their states, but industry groups are asking the federal government to play a larger role.
Meanwhile, the private sector is shifting into gear on its own and in partnership with the government.
1 scary stat: Prescription drugs needed by patients on ventilators are being filled only 53% of the time so far in April, as demand has skyrocketed, according to Vizient, a health care purchasing group.
What Gilead wants its remdesivir bottle to look like. Photo: U.S. Patent and Trademark Office
Gilead Sciences is still testing its potential coronavirus treatment, but here's a sign the company may be expecting good news: It has applied for a trademark for the drug's packaging, Axios' Bob Herman reports.
Why it matters: "The reason you make this trademark is because you think you're going to get a product out there soon," said Josh Gerben, a trademark lawyer who first noticed Gilead's application. "This is part of your brand protection."
The big picture: Gilead's drug, remdesivir, is seen as a promising candidate to treat the novel coronavirus, but is still undergoing clinical trials and hasn't been proven to work.
What they're saying: A Gilead spokesperson says the trademark application "is par for the course" and "entirely consistent with our stated responsibility to plan for a potential regulatory authorization should remdesivir be proven safe and effective."
Gilead has already trademarked the same blue-and-gray bottle top and white labeling in other federally approved drugs.
People losing their employer-based health insurance in the coronavirus economy would find a pretty stable Affordable Care Act market if they need it — not that the Trump administration is advertising that fact, Bob writes.
Why it matters: ACA plans will be an important backstop for some newly uninsured people, many of whom could likely find affordable coverage on the law's insurance marketplaces.
Where it stands: The average monthly premium for ACA coverage was down 3% in this year's enrollment period, compared with 2019, according to a federal report that was released earlier this month but not publicly promoted.
Yes, but: You won't hear much about those options from the Trump administration, which has been consistently hostile to the ACA and has declined to open up a special enrollment window that would let anyone who has been disrupted by the economic shutdown to buy coverage.